Log In
|
Recently Purchased
|
Favorites
|
My COAs
|
Cart
(0)
OVERVIEW
INNOVATIONS
COMPANY PROFILE
OUR EXPERTS
FACILITY
OVERVIEW
QUALITY CREDENTIALS
COA EXAMPLES
EXPIRY/RETEST DATES
OVERVIEW
SYNTHESIS
CERTIFIED SOLUTION
STANDARDS
CERTIFICATIONS
PACKAGING
INVENTORY MANAGEMENT
& DISTRIBUTION
OEM & PRIVATE LABEL
REQUEST QUOTE
CATALOG
NEW PRODUCTS
ORDERING INFORMATION
REQUEST/DOWNLOAD
CATALOG
REQUEST CUSTOM QUOTE
SEARCH COAs/SDSs
PAPERS & POSTER
PRESENTATIONS
CONTACT INFORMATION
INTERNATIONAL SALES
CAREERS
LOG IN/REQUEST LOGIN
FAVORITES
RECENTLY PURCHASED
QUICK ORDER
ORDER HISTORY
PURCHASES BY ITEM
MY ACCOUNT'S COAs & SDSs
VIEW CART/CHECK OUT
N-059 / N-059-1ML
updated item number format
Norbuprenorphine
1.0 mg/mL in Methanol |
Certified Reference Material
A new Certified Spiking Solution
®
suitable for use in clinical toxicology, forensic testing, or pain prescription monitoring.
Concentration:
1.0 mg/mL
Solvent:
Methanol
Unit Size:
1 mL/ampoule
CAS Number:
78715-23-8
Chemical Formula:
C
2
5
H
3
5
NO
4
Molecular Weight:
413.55
Certificate of Analysis:
need a different CoA?
US List Price:
$428.00 EA
Qty:
Components
Related Items
Additional Details
Technical Papers
B-035 / B-035-1ML
Buprenorphine-3ß-D-glucuronide, 100 μg/mL
$293.00
B-044 / B-044-1ML
Buprenorphine, 1.0 mg/mL
$154.00
B-060 / B-060-1ML
Buprenorphine-D
4
-3-β-D-glucuronide, 100 μg/mL
$342.00
B-901 / B-901-1ML
Buprenorphine-D
4
, 100 μg/mL
$46.90
B-902 / B-902-1ML
Buprenorphine, 100 μg/mL
$28.20
B-908 / B-908-1ML
Buprenorphine-D
4
, 1.0 mg/mL
$403.00
N-045 / N-045-1ML
Norbuprenorphine glucuronide, 100 μg/mL
$284.00
N-097 / N-097-1ML
Norbuprenorphine glucuronide-D
3
, 100 µg/mL
$306.00
N-912 / N-912-1ML
Norbuprenorphine, 100 μg/mL
$38.80
N-920 / N-920-1ML
Norbuprenorphine-D
3
, 100 μg/mL
$46.90
N-921 / N-921-1ML
Norbuprenorphine-D
3
, 1.0 mg/mL
$403.00
P-071 / P-071-1ML
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
$449.00
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1379 - no Health Canada import authorization required
read more about ordering regulated substances
Recommended Storage Condition
Freeze
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
View SDS
HS Code
3822.90.0000
▶
Accelerated Stability Studies by High Performance Liquid Chromatography | Greg Serna, Tamara Tarbox, Isil Dilek, Cerilliant, 2012
▶
Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
▶
Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
▶
High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
▶
LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
▶
LC/MS (TOF) Analysis of Opioid Drugs and Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm HILIC after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
▶
LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm F5 after Solid Phase Extraction (SPE) using Supel™-Select HLB | Sigma-Aldrich®, 2014
▶
Testing and Quantitation of Opioids in Urine and Serum by LC-TOF | Sharanya Reddy, Nonnie Danna, PerkinElmer Inc,, 2014
▶
Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015
©
2024
Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products
|
Sitemap
|
Privacy Policy
|
EHS Policy
|
Terms & Conditions
|
Contact